Ameritas Investment Company’s Genomic Health, Inc. GHDX Stock Holding History
Bought
Maintained
Sold
Ameritas Investment Company's GHDX Position: Q4 2019 in Review
Ameritas Investment Company sold out of Genomic Health, Inc. (GHDX) in Q4 2019, closing a stake of 200 shares — an estimated $14K sold.
Ameritas Investment Company first reported a position in GHDX in Q3 2019 and held it in 1 quarter. The position peaked at $14K in Q3 2019. 0 funds tracked by Wall St. Rank hold GHDX as of Q4 2019.
- Ameritas Investment Company reported no remaining Genomic Health, Inc. position as of Q4 2019 after selling out during the quarter.
- Ameritas Investment Company sold 200 Genomic Health, Inc. shares in Q4 2019, an estimated $14K.
- Ameritas Investment Company first reported a position in Genomic Health, Inc. in Q3 2019 and held it in 1 quarter.
- Ameritas Investment Company's Genomic Health, Inc. position peaked at $14K in Q3 2019.
- 0 funds tracked by Wall St. Rank held Genomic Health, Inc. as of Q4 2019.
Based on Ameritas Investment Company's 13F filing for Q4 2019, filed 18 Feb 2020.